Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- EUCRU
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Eucrates Biomedical Acquisition Corp.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Financial Services >Shell Companies
- Market cap
- -
- Ent value
- 3.93M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 1.11%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
EUCRU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | - |
| EPS (TTM) | 1.02 |
| FCF per share (TTM) | -0.30 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -830.73K |
| Net income (TTM) | 3.03M |
| EPS (TTM) | 1.02 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 18.86K |
| Net receivables | 0.00 |
| Total current assets | 132.20K |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 12.49M |
| Accounts payable | 5.08K |
| Short/Current long term debt | 60.06K |
| Total current liabilities | 65.14K |
| Total liabilities | 3.95M |
| Shareholder's equity | 8.54M |
| Net tangible assets | 8.54M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -881.39K |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -881.39K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 35.45% |
| Return on Assets | 24.23% |
| Return on Invested Capital | 35.20% |
| Cash Return on Invested Capital | -10.25% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| EUCRU | S&P500 | |
| Current price drop from All-time high | -9.97% | -13.62% |
| Highest price drop | -13.03% | -56.47% |
| Date of highest drop | 22 Aug 2022 | 9 Mar 2009 |
| Avg drop from high | -8.61% | -11.07% |
| Avg time to new high | 19 days | 12 days |
| Max time to new high | 559 days | 1805 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Small-cap
Description
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
Employees
0
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner